前列腺癌遗传生物标志物与病理及PSMA PET/CT特征的关联研究
本研究从TCGA数据库获取433例前列腺癌患者的mRNA测序和临床数据,分析Gleason评分(GS)>7与GS≤7组间的差异基因表达,并构建GS预测模型。同时收集27例患者的局部样本和PSMA PET/CT图像,对前列腺癌病灶进行mRNA测序,将TCGA数据集中的差异表达基因与局部数据集的PET相关指标进行Pearson相关性分析。结果发现多个基因与PSMA PET/CT影像特征显著相关,为基于遗传和影像生物标志物优化前列腺癌诊断与治疗提供了基础。
要点
- TCGA数据集分析发现174个差异表达基因,特征选择后保留53个。
- GS>7组6个基因、GS≤7组8个基因与PET参数显著相关。
核心结论
- 本研究识别出与前列腺癌PSMA PET/CT影像特征显著相关的遗传标志物,可能为优化诊断流程和基于遗传与影像生物标志物的个体化治疗提供基础。
研究设计与样本
- 从TCGA数据库检索433例前列腺癌患者的mRNA测序和临床数据,分析GS>7与GS≤7组间的差异基因表达,经单变量和多变量逻辑回归进行特征选择并构建GS预测模型。
- 收集27例患者的局部样本和图像,根治性前列腺切除术前进行PSMA PET/CT成像,对前列腺癌病灶行下一代测序mRNA测序,利用Pearson相关性分析TCGA差异表达基因与局部数据集PET相关指标的关联。
主要发现
- TCGA数据集中174个基因存在差异表达,特征选择后保留53个基因。
- 比较GS>7与GS≤7组间基因差异表达时,GS>7组6个基因(STMN2、CYP1A1、THRSP、LIPC、GBX2和SPSB4)与PET相关参数显著相关。
- GS≤7组8个基因(FBXL16、KLK14、DIRAS2、TERB2、PRAME、UTS2B、UGT2B15和LINC02798)与PET相关参数显著相关。
临床怎么用
- 研究提示可将遗传生物标志物与PSMA PET/CT影像特征联合分析,辅助前列腺癌的诊断流程优化和治疗方案制定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Prostate cancer is a prevalent disease with diverse tumor characteristics that complicate treatment. The integration of spatial patterns from prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT), pathology and expanding genomic data represents a groundbreaking advancement in histo-imaging genomics. The aim of this study was to elucidate the internetwork mapping between genetic biomarkers and PSMA PET/CT imaging in prostate cancer patients. RESULTS: mRNA sequencing and clinical data from 433 prostate cancer patients were retrieved from The Cancer Genome Atlas (TCGA) database. Differential gene expression between the Gleason score (GS) > 7 and GS ≤ 7 groups was analyzed. Feature selection was performed following the univariate and multivariate logistic regression analyses. A GS predictive model was developed using multivariate logistic regression. Additionally, local samples and images from 27 patients were collected. PSMA PET/CT imaging was performed before radical prostatectomy, and mRNA sequencing of prostate cancer lesions was conducted using next-generation sequencing. Differentially expressed genes identified from the TCGA dataset were subsequently analyzed for correlations with PET-related metrics in the local dataset by utilizing Pearson correlation analysis.Out of the TCGA dataset, 174 genes exhibited differential expression. After feature selection, 53 genes remained. In the local dataset, ten genes (EFNA2, CACNA1I, CA1, MYBPC3, CYP1A1, TLCD3B, LRTM2, GBX2, SPSB4, and GDF3) demonstrated significant associations with PET-related metrics. When comparing the differential expression of genes between the GS>7 and GS≤7 groups, six genes (STMN2, CYP1A1, THRSP, LIPC, GBX2, and SPSB4) in the GS>7 group and eight genes (FBXL16, KLK14, DIRAS2, TERB2, PRAME, UTS2B, UGT2B15, and LINC02798) in the GS≤7 group were significantly correlated with PET-related parameters. CONCLUSIONS: This study identified genetic markers significantly correlated with PSMA PET/CT imaging features in prostate cancer patients. These findings may provide a valuable foundation for optimizing prostate cancer diagnostic procedures and tailoring therapeutic approaches based on genetic and imaging biomarkers.
引用
- Qu L, Li K, Wang M, et al. Identifying genetics biomarkers in correlation with pathological and PSMA PET/CT characteristics in prostate cancer. EJNMMI Res. 2026. PMID: 42400802. doi:10.1186/s13550-026-01471-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。